Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Copenhagen – page 96

1 429 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Copenhagen at a glance
1 429
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

1 429 trials in Copenhagen

Open in trial search

Study on the Safety and Effects of BNT314 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:BioNTech SE

Phenylketonuria

Not recruiting

Study Comparing Sepiapterin and Sapropterin for Treating Phenylketonuria in Patients Aged 2 Years and Older

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Sepiapterin
  • Sponsor:PTC Therapeutics Inc.

Cardiac amyloidosis

Not recruiting

Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ALXN2220
  • Sponsor:Alexion Pharmaceuticals Inc.

Study on Zanubrutinib for Patients with Primary Cold Agglutinin Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Zanubrutinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Neuroblastoma+4

Not recruiting

Study on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Ribociclib
  • Sponsor:Novartis Pharma AG

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nerandomilast
  • Sponsor:Boehringer Ingelheim Espana S.A.

Osteochondrodysplasia

Not recruiting

Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Lonapegsomatropin
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Association International Extranodal Lymphoma Study Group (IELSG)

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi AATD Inc.

Osteoarthritis

Not recruiting

Study on the Effects of QUC398 for Patients with Knee Osteoarthritis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Novartis Pharma AG

Dermatitis atopic

Not recruiting

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Copenhagen

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in København includes cardiovascular diseases, with studies focused on acute heart failure. The research is aimed at improving treatment choices and helping clinicians better manage fluid overload and treatment response.

  • Optimizing care for acute decompensated heart failure
  • Evaluating diuretic treatment strategies
  • Addressing risk of diuretic resistance

These trials support more effective day-to-day management of patients with unstable heart conditions.

02 Digestive System Diseases

Research in digestive system diseases is centered on liver cirrhosis and its complications, especially ascites. The main purpose is to improve treatment planning and identify which patients are most likely to benefit from supportive therapy.

  • Studying cirrhosis with ascites
  • Validating response markers for human albumin therapy
  • Improving personalized treatment decisions

This work may help refine care for people with advanced liver disease.

03 Neoplasms

Trials in the field of neoplasms are examining localised dMMR colon cancer. The research is focused on assessing treatment effectiveness and understanding how well patients respond to newer cancer approaches.

  • Investigating colon cancer treatment response
  • Measuring clinical complete response
  • Supporting more tailored cancer care

These studies aim to strengthen precision treatment for selected colorectal cancer patients.

04 Nervous System Diseases

Clinical research in nervous system diseases involves acute ischemic stroke. The goal is to improve urgent stroke care by comparing treatment approaches and their impact on early neurological recovery.

  • Focusing on emergency stroke management
  • Assessing early neurological improvement
  • Comparing current care with thrombolysis approaches

These trials are designed to support faster, more effective treatment decisions after stroke.

05 Virus Diseases

Research in virus diseases includes work on chronic hepatitis B infection, with studies exploring immune-based approaches and treatment effects. The overall aim is to improve control of long-term viral infection and related liver health.

  • Studying hepatitis B infection
  • Testing new antibody-based therapy concepts
  • Supporting better long-term disease control

These trials reflect active interest in advancing antiviral research in Denmark.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.